Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × bicalutamide × Clear all

NCT00012090 2013-06-18

Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms